ATAI Life Sciences Files 8-K on Material Agreement

Ticker: ATAI · Form: 8-K · Filed: Jun 2, 2025 · CIK: 1840904

Atai Life Sciences N.V. 8-K Filing Summary
FieldDetail
CompanyAtai Life Sciences N.V. (ATAI)
Form Type8-K
Filed DateJun 2, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, equity-sale, 8-k

TL;DR

ATAI Life Sciences filed an 8-K on June 2, 2025, reporting a material definitive agreement and unregistered equity sales.

AI Summary

On June 2, 2025, ATAI Life Sciences N.V. filed an 8-K report detailing a material definitive agreement. The filing also disclosed unregistered sales of equity securities and included Regulation FD disclosures and financial statements. Specific details regarding the agreement and equity sales were not provided in the excerpt.

Why It Matters

This filing indicates significant corporate activity for ATAI Life Sciences, potentially involving new partnerships or financing, which could impact its stock price and future operations.

Risk Assessment

Risk Level: medium — The filing mentions a material definitive agreement and unregistered sales of equity, which can introduce uncertainty and potential dilution.

Key Players & Entities

  • ATAI Life Sciences N.V. (company) — Registrant
  • June 2, 2025 (date) — Date of earliest event reported
  • 001-40493 (other) — Commission File Number

FAQ

What is the nature of the material definitive agreement entered into by ATAI Life Sciences N.V. on June 2, 2025?

The provided excerpt of the 8-K filing does not specify the details of the material definitive agreement.

What type of equity securities were sold unregistered by ATAI Life Sciences N.V.?

The filing indicates unregistered sales of equity securities, but the specific type is not detailed in the excerpt.

What is the primary business of ATAI Life Sciences N.V. according to the filing?

ATAI Life Sciences N.V. is classified under Pharmaceutical Preparations [2834].

Where is the principal executive office of ATAI Life Sciences N.V. located?

The principal executive offices are located at Wallstraße 16, 10179 Berlin, Germany.

What is the former name of ATAI Life Sciences N.V. and when did the name change occur?

The former name was ATAI Life Sciences B.V., and the name change occurred on January 15, 2021.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding ATAI Life Sciences N.V. (ATAI).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.